{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:11:27Z","timestamp":1785413487232,"version":"3.56.0"},"reference-count":104,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Projects in Guangzhou","award":["202102070001"],"award-info":[{"award-number":["202102070001"]}]},{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan University","award":["NA."],"award-info":[{"award-number":["NA."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The growing global crisis of antimicrobial resistance (AMR) urgently demands non-classical therapies capable of evading established resistance mechanisms. Bacterial ferroptosis-like death, an iron-dependent process driven by lipid peroxidation, offers a promising strategy to circumvent conventional drug resistance. However, the clinical translation of ferroptosis-like inducers is hindered by poor water solubility and off-target systemic toxicity. Featuring tunable physicochemical characteristics and proven clinical biosafety, liposomes stand out as a viable platform to resolve these translational bottlenecks. Although antibacterial nanomedicines have been extensively investigated, the specific synergies between liposomal engineering and bacterial ferroptosis-like pathways remain underexplored. To bridge this gap, this review systematically delineates the molecular cascades of bacterial ferroptosis-like death and highlights unique mechanistic advantages of liposomes. Importantly, liposome-mediated ferroptosis-like antibacterial therapy faces prominent translational challenges, including biosafety concerns, insufficient stability, and targeting limitations. This review further outlines advanced liposomal engineering strategies to tackle the above obstacles and discusses pressing questions that should be the focus of future ferroptosis-like research. By integrating multidisciplinary research outcomes, this review may provide insights and feasible design guidelines to advance the translational development of liposomal ferroptosis-like inducers against AMR infections.<\/jats:p>","DOI":"10.3390\/antibiotics15080738","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:38:54Z","timestamp":1785411534000},"page":"738","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liposome-Mediated Bacterial Ferroptosis-like Death: A Novel Paradigm for Antimicrobial Therapy"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2506-5843","authenticated-orcid":false,"given":"Rui","family":"Yang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Pharmacy, Jinan University, Guangzhou 511443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwei","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Pharmacy, Jinan University, Guangzhou 511443, China"},{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3330-3537","authenticated-orcid":false,"given":"Xuejuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, College of Pharmacy, Jinan University, Guangzhou 511443, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"fuaa046","DOI":"10.1093\/femsre\/fuaa046","article-title":"Bacterial Cell Proliferation: From Molecules to Cells","volume":"45","author":"Meunier","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Linz, M.S., Mattappallil, A., Finkel, D., and Parker, D. (2023). Clinical Impact of Staphylococcus Aureus Skin and Soft Tissue Infections. Antibiotics, 12.","DOI":"10.3390\/antibiotics12030557"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105058","DOI":"10.1016\/j.micinf.2022.105058","article-title":"Therapeutic Potential of Kaempferol on Streptococcus Pneumoniae Infection","volume":"25","author":"Xu","year":"2023","journal-title":"Microbes Infect."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Engelsberger, V., Gerhard, M., and Mejias-Luque, R. (2024). Effects of Helicobacter Pylori Infection on Intestinal Microbiota, Immunity and Colorectal Cancer Risk. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1339750"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global Mortality Associated with 33 Bacterial Pathogens in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019","volume":"400","author":"Ikuta","year":"2022","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"112713","DOI":"10.1016\/j.intimp.2024.112713","article-title":"Molecular Immunological Mechanisms of Impaired Wound Healing in Diabetic Foot Ulcers (DFU), Current Therapeutic Strategies and Future Directions","volume":"139","author":"Mohsin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/IM9.0000000000000137","article-title":"Pulmonary Bacterial Infection and Liver Cirrhosis: Current Status and Treatment","volume":"6","author":"Zhao","year":"2024","journal-title":"Infect. Microbes Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.2174\/0109298673249381231130111352","article-title":"Treatment of MRSA Infection: Where Are We?","volume":"31","author":"Nazli","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"ref_9","unstructured":"(2026, March 29). Achieving Well-Being: A Global Framework for Integrating Well-Being into Public Health Utilizing A Health Promotion Approach. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240084858."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"174236","DOI":"10.1016\/j.scitotenv.2024.174236","article-title":"Harnessing Biotechnology for Penicillin Production: Opportunities and Environmental Considerations","volume":"946","author":"Haque","year":"2024","journal-title":"Sci. Total Environ."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.2019.21118","article-title":"Diagnosis and Treatment of Adults with Community-Acquired Pneumonia","volume":"323","author":"Olson","year":"2020","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/bbrj.bbrj_366_22","article-title":"Global Escalation in Carbapenem-Resistant Enterobacterales and Carbapenem-Resistant Acinetobacter Baumannii Infections: Serious Threat to Human Health from the Pink Corner","volume":"7","author":"Sannathimmappa","year":"2023","journal-title":"Biomed. Biotechnol. Res. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Munoz-Munoz, L., Ainsa, J.A., and Ramon-Garcia, S. (2023). Repurposing \u03b2-Lactams for the Treatment of Mycobacterium Kansasii Infections: An In Vitro Study. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020335"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1021\/acs.orglett.5c00378","article-title":"Phylogeny-Informed Discovery of New Glycopeptide Antibiotics Produced by a Minimal Biosynthetic Gene Cluster","volume":"27","author":"Li","year":"2025","journal-title":"Org. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-Infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Thy, M., Timsit, J.-F., and de Montmollin, E. (2023). Aminoglycosides for the Treatment of Severe Infection Due to Resistant Gram-Negative Pathogens. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050860"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bcp.2016.12.001","article-title":"Lincosamides: Chemical Structure, Biosynthesis, Mechanism of Action, Resistance, and Applications","volume":"133","author":"Spizek","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"250190","DOI":"10.1183\/20734735.0190-2025","article-title":"The Use of Macrolides in the Treatment of Community-Acquired Pneumonia: Risks and Benefits","volume":"21","author":"Israelsen","year":"2025","journal-title":"Breathe"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Martins, A.M., Marto, J.M., Johnson, J.L., and Graber, E.M. (2021). A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea. Antibiotics, 10.","DOI":"10.3390\/antibiotics10070757"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cao, D., Shen, Y., Huang, Y., Chen, B., Chen, Z., Ai, J., Liu, L., Yang, L., and Wei, Q. (2021). Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.658095"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Cummings, J.E., Woolhiser, L.K., Guglielmi, V., Wernsman, M., Romano, A., Pauly, S., Belisle, J.T., Walter, N.D., Robertson, G.T., and Slayden, R.A. (2025). Evaluating the Efficacy of HRZE-Based Regimens in a High-Burden Murine Model: A Back-Translational Assessment of Rifamycins and Moxifloxacin Substitutions in Tuberculosis Treatment. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1733648"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e02122","DOI":"10.1002\/slct.202502122","article-title":"Sulfonamides: Historical Perspectives, Therapeutic Insights, Applications, Challenges, and Synthetic Strategies","volume":"10","author":"Chhablani","year":"2025","journal-title":"ChemistrySelect"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e01859-24","DOI":"10.1128\/aac.01859-24","article-title":"Clinical Outcomes and Pharmacokinetics\/Pharmacodynamics of Intravenous Polymyxin B Treatment for Various Site Carbapenem-Resistant Gram-Negative Bacterial Infections: A Prospective Observational Multicenter Study","volume":"69","author":"Yu","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e202401057","DOI":"10.1002\/cphc.202401057","article-title":"Navigating Antibiotic Resistance in Gram-Negative Bacteria: Current Challenges and Emerging Therapeutic Strategies","volume":"26","author":"Kumari","year":"2025","journal-title":"ChemPhysChem"},{"key":"ref_26","unstructured":"(2025, December 16). New Report Calls for Urgent Action to Avert Antimicrobial Resistance Crisis. Available online: https:\/\/www.who.int\/news\/item\/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial Resistance in ESKAPE Pathogens","volume":"33","author":"Forde","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"107228","DOI":"10.1016\/j.bpc.2024.107228","article-title":"Metallo-\u03b2-Lactamase Inhibitors: A Continuing Challenge for Combating Antibiotic Resistance","volume":"309","author":"Kang","year":"2024","journal-title":"Biophys. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"001333","DOI":"10.1099\/mic.0.001333","article-title":"Role of Bacterial Efflux Pumps in Antibiotic Resistance, Virulence, and Strategies to Discover Novel Efflux Pump Inhibitors","volume":"169","author":"Gaurav","year":"2023","journal-title":"Microbiology"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhang, L., Tian, X., Sun, L., Mi, K., Wang, R., Gong, F., and Huang, L. (2024). Bacterial Efflux Pump Inhibitors Reduce Antibiotic Resistance. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16020170"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"110422","DOI":"10.1016\/j.abb.2025.110422","article-title":"Methylation of Immature Small Ribosomal Subunits by Methyltransferases Conferring Aminoglycoside Resistance","volume":"769","author":"Mocibob","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.molmed.2020.05.001","article-title":"Antibiotic Resistance by Enzymatic Modification of Antibiotic Targets","volume":"26","author":"Schaenzer","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12668-025-01866-x","article-title":"Frustrating the Serenity of Bacterial Biofilms by Bristly Reduced Graphene Oxide Sheets","volume":"15","author":"Biswas","year":"2025","journal-title":"BioNanoScience"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sharma, S., Mohler, J., Mahajan, S.D., Schwartz, S.A., Bruggemann, L., and Aalinkeel, R. (2023). Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms, 11.","DOI":"10.3390\/microorganisms11061614"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/17460441.2018.1514386","article-title":"The Development of Efflux Pump Inhibitors to Treat Gram-Negative Infections","volume":"13","author":"Blanco","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s42003-024-07168-4","article-title":"Advances in Methods and Concepts Provide New Insight into Antibiotic Fluxes across the Bacterial Membrane","volume":"7","author":"Vergalli","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.molcel.2022.10.024","article-title":"Efflux-Linked Accelerated Evolution of Antibiotic Resistance at a Population Edge","volume":"82","author":"Bhattacharyya","year":"2022","journal-title":"Mol. Cell"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Galinier, A., Delan-Forino, C., Foulquier, E., Lakhal, H., and Pompeo, F. (2023). Recent Advances in Peptidoglycan Synthesis and Regulation in Bacteria. Biomolecules, 13.","DOI":"10.3390\/biom13050720"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.mib.2024.102433","article-title":"Gram-Negative Endolysins: Overcoming the Outer Membrane Obstacle","volume":"78","author":"Sisson","year":"2024","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Napole\u00e3o, T.H., da Silva, L.T.L., Viana, P.E., and Salles, F.G.R. (2025). Lectins as Natural Antibiofilm Agents in the Fight Against Antibiotic Resistance: A Review. Molecules, 30.","DOI":"10.3390\/molecules30163395"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1097\/MS9.0000000000003106","article-title":"Antimicrobial Peptides: A Promising Frontier to Combat Antibiotic Resistant Pathogens","volume":"87","author":"Shriwastav","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Beckman, R.L., Martinez, B., Santiago, F.Z., Echeverria, G.N., Pinheiro, B.V., Torres, M.D.T., Suits, L., Garcia, S., Wantuch, P.L., and De La Fuente-nunez, C. (2025). Molecular Response to the Non-Lytic Peptide Bac7 (1-35) Triggers Disruption of Klebsiella Pneumoniae Biofilm. PLoS Pathog., 21.","DOI":"10.1101\/2025.08.08.669280"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Gagat, P., Ostrowka, M., Duda-Madej, A., and Mackiewicz, P. (2024). Enhancing Antimicrobial Peptide Activity through Modifications of Charge, Hydrophobicity, and Structure. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910821"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2411476","DOI":"10.1002\/smll.202411476","article-title":"From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity","volume":"22","author":"Rossetti","year":"2025","journal-title":"Small"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/scbi.1997.0064","article-title":"Multidrug Transporters from Bacteria to Man: Similarities in Structure and Function","volume":"8","author":"Konings","year":"1997","journal-title":"Semin. Cancer Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e70280","DOI":"10.1002\/mco2.70280","article-title":"Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside","volume":"6","author":"Moghadam","year":"2025","journal-title":"MedComm"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez, A.A., Otero-Gonz\u00e1lez, A., Ghattas, M., and St\u00e4ndker, L. (2021). Discovery, Optimization, and Clinical Application of Natural Antimicrobial Peptides. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101381"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Khan, F.M., Rasheed, F., Yang, Y., Liu, B., and Zhang, R. (2024). Endolysins: A New Antimicrobial Agent against Antimicrobial Resistance. Strategies and Opportunities in Overcoming the Challenges of Endolysins against Gram-Negative Bacteria. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1385261"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Rouvier, F., Brunel, J.-M., Pages, J.-M., and Vergalli, J. (2025). Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps. Antibiotics, 14.","DOI":"10.3390\/antibiotics14080778"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Karaiskos, I., Galani, I., Daikos, G.L., and Giamarellou, H. (2025). Breaking Through Resistance: A Comparative Review of New Beta-Lactamase Inhibitors (Avibactam, Vaborbactam, Relebactam) Against Multidrug-Resistant Superbugs. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050528"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/acsinfecdis.4c00091","article-title":"Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps","volume":"10","author":"Duffey","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e14465","DOI":"10.1111\/1751-7915.14465","article-title":"Engineering Strategies and Challenges of Endolysin as an Antibacterial Agent against Gram-negative Bacteria","volume":"17","author":"Zheng","year":"2024","journal-title":"Microb. Biotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: Mechanisms, Biology and Role in Disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ Oxidoreductase FSP1 Acts Parallel to GPX4 to Inhibit Ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.cell.2025.03.019","article-title":"ALDH7A1 Protects against Ferroptosis by Generating Membrane NADH and Regulating FSP1","volume":"188","author":"Yang","year":"2025","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"368","DOI":"10.21037\/atm-21-6942","article-title":"The Critical Role and Molecular Mechanisms of Ferroptosis in Antioxidant Systems: A Narrative Review","volume":"10","author":"Liu","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"103788","DOI":"10.1016\/j.redox.2025.103788","article-title":"DHODH-Mediated Mitochondrial Redox Homeostasis: A Novel Ferroptosis Regulator and Promising Therapeutic Target","volume":"85","author":"Cao","year":"2025","journal-title":"Redox Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41392-021-00656-7","article-title":"DHODH Tangoing with GPX4 on the Ferroptotic Stage","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening Horizons: The Role of Ferroptosis in Cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100916","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming Cancer Chemotherapy Resistance by the Induction of Ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","article-title":"Ferroptosis, Necroptosis, and Pyroptosis in Anticancer Immunity","volume":"13","author":"Tang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"217758","DOI":"10.1016\/j.ccr.2026.217758","article-title":"Bacterial Ferroptosis-like Death: Mechanisms and Emerging Therapeutic Strategies","volume":"557","author":"Xiao","year":"2026","journal-title":"Coord. Chem. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"106794","DOI":"10.1016\/j.ijantimicag.2023.106794","article-title":"Ferric Chloride Induces Ferroptosis in Pseudomonas Aeruginosa and Heals Wound Infection in a Mouse Model","volume":"61","author":"Huang","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4014\/jmb.2307.07002","article-title":"Ferroptosis-Like Death in Microorganisms: A Novel Programmed Cell Death Following Lipid Peroxidation","volume":"33","author":"Kwun","year":"2023","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"586869","DOI":"10.2147\/IJN.S586869","article-title":"Ferroptosis-Like Death: An Emerging Innovative Antibacterial Strategy","volume":"21","author":"Luo","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1021\/acsnano.3c02365","article-title":"Hybrid Biomimetic Membrane Coated Particles-Mediated Bacterial Ferroptosis for Acute MRSA Pneumonia","volume":"17","author":"Hu","year":"2023","journal-title":"ACS Nano"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"167360","DOI":"10.1016\/j.cej.2025.167360","article-title":"Trained Membrane-Decorated Smart Nanocage: A Broad-Spectrum Antibacterial System Inducing Bacterial Ferroptosis via Metabolic Reprogramming and ROS Cascade Reaction","volume":"522","author":"Lu","year":"2025","journal-title":"Chem. Eng. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e202405558","DOI":"10.1002\/slct.202405558","article-title":"Preparation and Characterization of Silver-Loaded Magnetic Activated Carbon Produced from Crataegus Monogyna for Antimicrobial and Antioxidant Applications","volume":"10","author":"Baran","year":"2025","journal-title":"ChemistrySelect"},{"key":"ref_71","first-page":"241","article-title":"Sonotheranostic Nanosideromycin Eradicates Bacterial Biofilm Infections via Ultrasound-Detonated ROS Generation and Ferroptosis-like Death","volume":"55","author":"Pang","year":"2026","journal-title":"Bioact. Mater."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","article-title":"Auranofin Mitigates Systemic Iron Overload and Induces Ferroptosis via Distinct Mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"160975","DOI":"10.1016\/j.cej.2025.160975","article-title":"Highly Efficient Sterilization of Biogenic FeS2 Nanoparticles: Mechanism and Inhibition of Antibiotic Resistance","volume":"509","author":"He","year":"2025","journal-title":"Chem. Eng. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1039\/D2TB02161G","article-title":"Nanomedicine-Mediated Ferroptosis Targeting Strategies for Synergistic Cancer Therapy","volume":"11","author":"Yin","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"rbad004","DOI":"10.1093\/rb\/rbad004","article-title":"Ferroptosis: Challenges and Opportunities for Nanomaterials in Cancer Therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Regen. Biomater."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an Emerging Platform for Cancer Therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"100209","DOI":"10.1016\/j.nxnano.2025.100209","article-title":"Liposomes for Drug Delivery: Classification, Therapeutic Applications, and Limitations","volume":"8","author":"Chelliah","year":"2025","journal-title":"Next Nanotechnol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41557-024-01705-8","article-title":"Coacervate Vesicles Assembled by Liquid-Liquid Phase Separation Improve Delivery of Biopharmaceuticals","volume":"17","author":"Wen","year":"2025","journal-title":"Nat. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ludtke, F.L., Silva, T.J., da Silva, M.G., Hashimoto, J.C., and Ribeiro, A.P.B. (2025). Lipid Nanoparticles: Formulation, Production Methods and Characterization Protocols. Foods, 14.","DOI":"10.3390\/foods14060973"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103206","DOI":"10.1016\/j.cis.2024.103206","article-title":"Recent Progress in Stimuli-Responsive Polymeric Micelles for Targeted Delivery of Functional Nanoparticles","volume":"330","author":"Cao","year":"2024","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"4557622","DOI":"10.1155\/ijbm\/4557622","article-title":"Metallic Nanoparticles Applications in Neurological Disorders: A Review","volume":"2025","author":"Montes","year":"2025","journal-title":"Int. J. Biomater."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12951-025-03113-7","article-title":"A Systematic Review of Nanocarriers Used in Medicine and beyond\u2014Definition and Categorization Framework","volume":"23","author":"Gressler","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41420-024-01825-7","article-title":"Ferroptosis: Emerging Mechanisms, Biological Function, and Therapeutic Potential in Cancer and Inflammation","volume":"10","author":"Jin","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric Micelles in Drug Delivery: An Insight of the Techniques for Their Characterization and Assessment in Biorelevant Conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/01932691.2023.2295024","article-title":"TPGS\/Soluplus\u00ae Blended Micelles: An Effective Strategy for Improving Loading Capacity of Ferroptosis Inducer Erastin","volume":"46","author":"Liu","year":"2025","journal-title":"J. Dispers. Sci. Technol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"37383","DOI":"10.1021\/acsami.5c07366","article-title":"The Nanocarrier Landscape-Evaluating Key Drug Delivery Vehicles and Their Capabilities: A Translational Perspective","volume":"17","author":"Fathi","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"23520","DOI":"10.1039\/D4RA04069D","article-title":"Advances in Active Targeting of Ligand-Directed Polymeric Nanomicelles via Exploiting Overexpressed Cellular Receptors for Precise Nanomedicine","volume":"14","author":"Agwa","year":"2024","journal-title":"RSC Adv."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"117329","DOI":"10.1016\/j.jpba.2025.117329","article-title":"Rapid One-Tube Sputum Processing for Tuberculosis Diagnosis via Azide-Functionalized Magnetic Nanoplatforms with Selective Bacterial Capture","volume":"271","author":"Tural","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Avgoustakis, K., and Angelopoulou, A. (2024). Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16020179"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2022.2152134","article-title":"Ferric-Loaded Lipid Nanoparticles Inducing Ferroptosis-like Cell Death for Antibacterial Wound Healing","volume":"30","author":"Zhou","year":"2023","journal-title":"Drug Deliv."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Miguel, R.D.A., Hirata, A.S., Jimenez, P.C., Lopes, L.B., and Costa-Lotufo, L.V. (2022). Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081722"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2500From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12951-025-03442-7","article-title":"Nano-Formulations in Disease Therapy: Designs, Advances, Challenges, and Future Directions","volume":"23","author":"Shi","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: Structure, Composition, Types, and Clinical Applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Faustino, C., and Pinheiro, L. (2020). Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010029"},{"key":"ref_96","first-page":"817","article-title":"Liposomes and Liposome-like Nanoparticles: From Anti-Fungal Infection to the COVID-19 Pandemic Treatment","volume":"17","author":"He","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Ferreira, M., Ogren, M., Dias, J.N.R., Silva, M., Gil, S., Tavares, L., Aires-da-Silva, F., Gaspar, M.M., and Aguiar, S.I. (2021). Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance. Molecules, 26.","DOI":"10.3390\/molecules26072047"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Eleraky, N.E., Allam, A., Hassan, S.B., and Omar, M.M. (2020). Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020142"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41579-020-0420-1","article-title":"Nanomaterial-Based Therapeutics for Antibiotic-Resistant Bacterial Infections","volume":"19","author":"Makabenta","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"571655","DOI":"10.2147\/IJN.S571655","article-title":"Nanomaterial-Induced Bacterial Ferroptosis-Like Death: A Novel Strategy to Counteract Antimicrobial Resistance","volume":"21","author":"Wu","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Li, F., and Chen, X. (2026). Recent Progress in Understanding Ferroptosis Mechanisms in Infectious Diseases. Front. Cell. Infect. Microbiol., 16.","DOI":"10.3389\/fcimb.2026.1778721"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"100279","DOI":"10.1016\/j.mtbio.2022.100279","article-title":"Erythrocyte Membrane-Camouflaged Nanoparticles as Effective and Biocompatible Platform: Either Autologous or Allogeneic Erythrocyte-Derived","volume":"15","author":"Dai","year":"2022","journal-title":"Mater. Today Bio"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"124046","DOI":"10.1016\/j.ijpharm.2024.124046","article-title":"Liposomal Drug Delivery Strategies to Eradicate Bacterial Biofilms: Challenges, Recent Advances, and Future Perspectives","volume":"655","author":"Panthi","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"15523","DOI":"10.1039\/D5NR00921A","article-title":"Cobalt-Intercalated \u03b1-MoO3 Nanoribbons Enhance Peroxidase Mimetic Activity and Photothermal Effects for Sterilization","volume":"17","author":"Zhang","year":"2025","journal-title":"Nanoscale"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/738\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:55:20Z","timestamp":1785412520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":104,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["antibiotics15080738"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15080738","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]}}}